Too read more about this study, click here.
Tuesday, 4 August 2020
Fusion proteins in childhood cancers
The National Cancer Institute (NCI) recently launched the Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium, consisting of a group of researchers with expertise in cancer biology, proteomics, genomics, computational biology, and pharmacology. The purpose of Fu OnC2 is to investigate difficult-to-treat "cancers driven by fusion proteins in children and young adults", with emphasis on soft tissue cancers such as synovial sarcoma, rhabdomyosarcoma, as well as ependymoma, a type of brain cancer.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment